Cargando…
Prevalence, Risk Factors, and Molecular Epidemiology of Intestinal Carbapenem-Resistant Pseudomonas aeruginosa
Pseudomonas aeruginosa may become multidrug-resistant (MDR) due to multiple inherited and acquired resistance mechanisms. The human gastrointestinal tract is known as a reservoir of P. aeruginosa and its resistance genes. In this study, we collected 76 intestinal carbapenem-resistant P. aeruginosa (...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8612150/ https://www.ncbi.nlm.nih.gov/pubmed/34817230 http://dx.doi.org/10.1128/Spectrum.01344-21 |
_version_ | 1784603422069096448 |
---|---|
author | Hu, Yanyan Qing, Yan Chen, Jiawei Liu, Congcong Lu, Jiayue Wang, Qi Zhen, Shufang Zhou, Hongwei Huang, Ling Zhang, Rong |
author_facet | Hu, Yanyan Qing, Yan Chen, Jiawei Liu, Congcong Lu, Jiayue Wang, Qi Zhen, Shufang Zhou, Hongwei Huang, Ling Zhang, Rong |
author_sort | Hu, Yanyan |
collection | PubMed |
description | Pseudomonas aeruginosa may become multidrug-resistant (MDR) due to multiple inherited and acquired resistance mechanisms. The human gastrointestinal tract is known as a reservoir of P. aeruginosa and its resistance genes. In this study, we collected 76 intestinal carbapenem-resistant P. aeruginosa (CRPA) strains from clinical inpatients admitted to our hospital from 2014 to 2019, together with their medical data. We aim to analyze the clinical risk factors associated with CRPA infection and its molecular features. We found that the prevalence of CRPA in P. aeruginosa strains was 41.3% (95% confidence interval [CI], 34.1 to 48.8%). We also identified four variables associated with intestinal CRPA positivity, prior antibiotic exposure to aminoglycosides or carbapenems, underlying diabetes mellitus, and extraintestinal P. aeruginosa isolation. bla(KPC-2) is the only detected carbapenemase gene, accounting for 21.1% of CRPA strains. The genetic environment showed that the bla(KPC-2) gene was flanked immediately by ISKpn8 and ISKpn6 and several other mobile elements further upstream or downstream. Four sequence types (STs) were identified, with ST463 as the dominant sequence type. In conclusion, screening for P. aeruginosa colonization upon hospital admission could reduce the risk of P. aeruginosa infection and spread of CRPA in the hospital. IMPORTANCE Pseudomonas aeruginosa may become multidrug-resistant (MDR) due to multiple inherited and acquired resistance mechanisms. The human gastrointestinal tract is known as a reservoir of P. aeruginosa and its resistance genes. Risk factor analysis and molecular epidemiology are critical for preventing their potential dissemination. Here, we identified four risk factors associated with intestinal CRPA—prior antibiotic exposure to aminoglycosides or carbapenems, underlying diabetes mellitus, and extraintestinal P. aeruginosa isolation. Further, we found similar genetic environments with several mobile elements surrounding the bla(KPC) gene, a carbapenemase gene only detected in intestinal CRPA strains in this study. These findings are of significant public health importance, as the information will facilitate the control of the emergence and spread of CRPA. |
format | Online Article Text |
id | pubmed-8612150 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | American Society for Microbiology |
record_format | MEDLINE/PubMed |
spelling | pubmed-86121502021-11-29 Prevalence, Risk Factors, and Molecular Epidemiology of Intestinal Carbapenem-Resistant Pseudomonas aeruginosa Hu, Yanyan Qing, Yan Chen, Jiawei Liu, Congcong Lu, Jiayue Wang, Qi Zhen, Shufang Zhou, Hongwei Huang, Ling Zhang, Rong Microbiol Spectr Research Article Pseudomonas aeruginosa may become multidrug-resistant (MDR) due to multiple inherited and acquired resistance mechanisms. The human gastrointestinal tract is known as a reservoir of P. aeruginosa and its resistance genes. In this study, we collected 76 intestinal carbapenem-resistant P. aeruginosa (CRPA) strains from clinical inpatients admitted to our hospital from 2014 to 2019, together with their medical data. We aim to analyze the clinical risk factors associated with CRPA infection and its molecular features. We found that the prevalence of CRPA in P. aeruginosa strains was 41.3% (95% confidence interval [CI], 34.1 to 48.8%). We also identified four variables associated with intestinal CRPA positivity, prior antibiotic exposure to aminoglycosides or carbapenems, underlying diabetes mellitus, and extraintestinal P. aeruginosa isolation. bla(KPC-2) is the only detected carbapenemase gene, accounting for 21.1% of CRPA strains. The genetic environment showed that the bla(KPC-2) gene was flanked immediately by ISKpn8 and ISKpn6 and several other mobile elements further upstream or downstream. Four sequence types (STs) were identified, with ST463 as the dominant sequence type. In conclusion, screening for P. aeruginosa colonization upon hospital admission could reduce the risk of P. aeruginosa infection and spread of CRPA in the hospital. IMPORTANCE Pseudomonas aeruginosa may become multidrug-resistant (MDR) due to multiple inherited and acquired resistance mechanisms. The human gastrointestinal tract is known as a reservoir of P. aeruginosa and its resistance genes. Risk factor analysis and molecular epidemiology are critical for preventing their potential dissemination. Here, we identified four risk factors associated with intestinal CRPA—prior antibiotic exposure to aminoglycosides or carbapenems, underlying diabetes mellitus, and extraintestinal P. aeruginosa isolation. Further, we found similar genetic environments with several mobile elements surrounding the bla(KPC) gene, a carbapenemase gene only detected in intestinal CRPA strains in this study. These findings are of significant public health importance, as the information will facilitate the control of the emergence and spread of CRPA. American Society for Microbiology 2021-11-24 /pmc/articles/PMC8612150/ /pubmed/34817230 http://dx.doi.org/10.1128/Spectrum.01344-21 Text en Copyright © 2021 Hu et al. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Research Article Hu, Yanyan Qing, Yan Chen, Jiawei Liu, Congcong Lu, Jiayue Wang, Qi Zhen, Shufang Zhou, Hongwei Huang, Ling Zhang, Rong Prevalence, Risk Factors, and Molecular Epidemiology of Intestinal Carbapenem-Resistant Pseudomonas aeruginosa |
title | Prevalence, Risk Factors, and Molecular Epidemiology of Intestinal Carbapenem-Resistant Pseudomonas aeruginosa |
title_full | Prevalence, Risk Factors, and Molecular Epidemiology of Intestinal Carbapenem-Resistant Pseudomonas aeruginosa |
title_fullStr | Prevalence, Risk Factors, and Molecular Epidemiology of Intestinal Carbapenem-Resistant Pseudomonas aeruginosa |
title_full_unstemmed | Prevalence, Risk Factors, and Molecular Epidemiology of Intestinal Carbapenem-Resistant Pseudomonas aeruginosa |
title_short | Prevalence, Risk Factors, and Molecular Epidemiology of Intestinal Carbapenem-Resistant Pseudomonas aeruginosa |
title_sort | prevalence, risk factors, and molecular epidemiology of intestinal carbapenem-resistant pseudomonas aeruginosa |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8612150/ https://www.ncbi.nlm.nih.gov/pubmed/34817230 http://dx.doi.org/10.1128/Spectrum.01344-21 |
work_keys_str_mv | AT huyanyan prevalenceriskfactorsandmolecularepidemiologyofintestinalcarbapenemresistantpseudomonasaeruginosa AT qingyan prevalenceriskfactorsandmolecularepidemiologyofintestinalcarbapenemresistantpseudomonasaeruginosa AT chenjiawei prevalenceriskfactorsandmolecularepidemiologyofintestinalcarbapenemresistantpseudomonasaeruginosa AT liucongcong prevalenceriskfactorsandmolecularepidemiologyofintestinalcarbapenemresistantpseudomonasaeruginosa AT lujiayue prevalenceriskfactorsandmolecularepidemiologyofintestinalcarbapenemresistantpseudomonasaeruginosa AT wangqi prevalenceriskfactorsandmolecularepidemiologyofintestinalcarbapenemresistantpseudomonasaeruginosa AT zhenshufang prevalenceriskfactorsandmolecularepidemiologyofintestinalcarbapenemresistantpseudomonasaeruginosa AT zhouhongwei prevalenceriskfactorsandmolecularepidemiologyofintestinalcarbapenemresistantpseudomonasaeruginosa AT huangling prevalenceriskfactorsandmolecularepidemiologyofintestinalcarbapenemresistantpseudomonasaeruginosa AT zhangrong prevalenceriskfactorsandmolecularepidemiologyofintestinalcarbapenemresistantpseudomonasaeruginosa |